Concepts (145)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Intermediate Filaments | 1 | 2021 | 77 | 0.89 | Why? |
| tau Proteins | 1 | 2021 | 162 | 0.83 | Why? |
| Neurofilament Proteins | 1 | 2021 | 202 | 0.81 | Why? |
| Exosome Multienzyme Ribonuclease Complex | 1 | 2018 | 5 | 0.76 | Why? |
| Myositis | 2 | 2018 | 185 | 0.72 | Why? |
| Dermatomyositis | 2 | 2018 | 193 | 0.64 | Why? |
| Malnutrition | 3 | 2021 | 932 | 0.56 | Why? |
| Muscle, Skeletal | 1 | 2018 | 915 | 0.44 | Why? |
| Cognitive Dysfunction | 1 | 2020 | 1389 | 0.37 | Why? |
| Autoimmune Diseases | 2 | 2019 | 1996 | 0.35 | Why? |
| Dyspnea | 1 | 2020 | 3847 | 0.33 | Why? |
| Autoantibodies | 1 | 2018 | 2094 | 0.32 | Why? |
| Survivors | 4 | 2021 | 2619 | 0.29 | Why? |
| Stress Disorders, Post-Traumatic | 2 | 2020 | 2963 | 0.28 | Why? |
| Adiposity | 2 | 2021 | 329 | 0.22 | Why? |
| Glial Fibrillary Acidic Protein | 1 | 2021 | 138 | 0.22 | Why? |
| Ubiquitin Thiolesterase | 1 | 2021 | 69 | 0.22 | Why? |
| Adiponectin | 1 | 2021 | 123 | 0.21 | Why? |
| Hepcidins | 1 | 2020 | 97 | 0.21 | Why? |
| Leptin | 1 | 2021 | 141 | 0.20 | Why? |
| Obesity, Abdominal | 1 | 2021 | 167 | 0.20 | Why? |
| Creatine Kinase | 2 | 2018 | 386 | 0.19 | Why? |
| Intra-Abdominal Fat | 1 | 2021 | 227 | 0.18 | Why? |
| Physical Endurance | 1 | 2018 | 107 | 0.17 | Why? |
| Serum Amyloid P-Component | 1 | 2019 | 193 | 0.17 | Why? |
| Interleukin-1 | 1 | 2021 | 438 | 0.17 | Why? |
| Electromyography | 1 | 2018 | 278 | 0.16 | Why? |
| Muscle Strength | 1 | 2018 | 317 | 0.15 | Why? |
| Pulmonary Edema | 1 | 2020 | 430 | 0.15 | Why? |
| Cognition Disorders | 1 | 2021 | 574 | 0.15 | Why? |
| Overweight | 1 | 2021 | 916 | 0.14 | Why? |
| Weight Loss | 1 | 2020 | 826 | 0.14 | Why? |
| Coronary Disease | 1 | 2020 | 645 | 0.13 | Why? |
| Interleukin 1 Receptor Antagonist Protein | 1 | 2021 | 1165 | 0.12 | Why? |
| Vasculitis | 1 | 2019 | 691 | 0.12 | Why? |
| Kaplan-Meier Estimate | 2 | 2020 | 4260 | 0.12 | Why? |
| Extracellular Traps | 1 | 2021 | 1036 | 0.12 | Why? |
| Follow-Up Studies | 5 | 2021 | 17020 | 0.11 | Why? |
| Depressive Disorder, Major | 1 | 2020 | 852 | 0.11 | Why? |
| Respiratory Function Tests | 1 | 2018 | 1755 | 0.11 | Why? |
| Aftercare | 1 | 2020 | 1637 | 0.11 | Why? |
| Recovery of Function | 1 | 2021 | 2461 | 0.10 | Why? |
| Regression Analysis | 1 | 2018 | 2484 | 0.10 | Why? |
| Anthropometry | 2 | 2021 | 233 | 0.10 | Why? |
| Nutritional Status | 1 | 2020 | 1403 | 0.10 | Why? |
| C-Reactive Protein | 3 | 2020 | 7972 | 0.09 | Why? |
| Neutrophils | 2 | 2021 | 5476 | 0.08 | Why? |
| Anxiety Disorders | 1 | 2020 | 2290 | 0.08 | Why? |
| Biomarkers | 4 | 2021 | 23361 | 0.07 | Why? |
| Aged | 12 | 2021 | 215776 | 0.07 | Why? |
| Inpatients | 1 | 2020 | 5161 | 0.07 | Why? |
| Italy | 7 | 2021 | 38444 | 0.07 | Why? |
| Radiography, Thoracic | 1 | 2021 | 5486 | 0.07 | Why? |
| Middle Aged | 13 | 2021 | 270681 | 0.07 | Why? |
| Kidney Failure, Chronic | 1 | 2020 | 3222 | 0.07 | Why? |
| Prospective Studies | 7 | 2021 | 43301 | 0.07 | Why? |
| Male | 15 | 2021 | 367725 | 0.06 | Why? |
| Interleukin-6 | 1 | 2021 | 7522 | 0.06 | Why? |
| Female | 14 | 2021 | 380317 | 0.06 | Why? |
| Densitometry | 1 | 2021 | 40 | 0.06 | Why? |
| Citrullination | 1 | 2021 | 85 | 0.06 | Why? |
| Magnetic Resonance Imaging | 1 | 2018 | 6551 | 0.05 | Why? |
| Mental Disorders | 2 | 2021 | 6742 | 0.05 | Why? |
| Waist Circumference | 1 | 2021 | 199 | 0.05 | Why? |
| Humans | 20 | 2021 | 930598 | 0.05 | Why? |
| Obesity | 1 | 2021 | 7388 | 0.05 | Why? |
| Respiratory Insufficiency | 1 | 2021 | 7301 | 0.05 | Why? |
| Pneumonia, Viral | 4 | 2020 | 243684 | 0.05 | Why? |
| Myositis, Inclusion Body | 1 | 2018 | 10 | 0.05 | Why? |
| Quality of Life | 1 | 2021 | 9820 | 0.05 | Why? |
| Coronavirus Infections | 4 | 2020 | 253789 | 0.05 | Why? |
| Polymyositis | 1 | 2018 | 25 | 0.05 | Why? |
| Antibodies, Monoclonal, Humanized | 1 | 2021 | 9335 | 0.05 | Why? |
| Pericardium | 1 | 2021 | 228 | 0.05 | Why? |
| Takayasu Arteritis | 1 | 2019 | 83 | 0.05 | Why? |
| Hypertension | 1 | 2020 | 8895 | 0.05 | Why? |
| Lymphocyte Count | 2 | 2020 | 4758 | 0.04 | Why? |
| Acute-Phase Proteins | 1 | 2019 | 177 | 0.04 | Why? |
| Cohort Studies | 2 | 2020 | 36005 | 0.04 | Why? |
| Diabetes Mellitus | 1 | 2020 | 8207 | 0.04 | Why? |
| Inflammation | 4 | 2021 | 13255 | 0.04 | Why? |
| Tomography, X-Ray Computed | 2 | 2021 | 25144 | 0.04 | Why? |
| Survival Analysis | 2 | 2021 | 7592 | 0.04 | Why? |
| Giant Cell Arteritis | 1 | 2019 | 137 | 0.04 | Why? |
| Platelet Activation | 1 | 2021 | 660 | 0.04 | Why? |
| Blood Proteins | 1 | 2020 | 551 | 0.04 | Why? |
| Granulomatosis with Polyangiitis | 1 | 2019 | 161 | 0.04 | Why? |
| Severe Acute Respiratory Syndrome | 1 | 2020 | 12361 | 0.04 | Why? |
| Exercise Tolerance | 1 | 2021 | 634 | 0.04 | Why? |
| Disease-Free Survival | 1 | 2021 | 1654 | 0.04 | Why? |
| Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | 1 | 2019 | 235 | 0.04 | Why? |
| Respiration, Artificial | 1 | 2021 | 22116 | 0.04 | Why? |
| Neuropsychological Tests | 1 | 2021 | 954 | 0.04 | Why? |
| Severity of Illness Index | 5 | 2021 | 48226 | 0.04 | Why? |
| Iron | 1 | 2020 | 619 | 0.04 | Why? |
| Prednisone | 1 | 2019 | 652 | 0.04 | Why? |
| Complement Activation | 1 | 2021 | 949 | 0.03 | Why? |
| Creatinine | 1 | 2020 | 1443 | 0.03 | Why? |
| Obsessive-Compulsive Disorder | 1 | 2020 | 486 | 0.03 | Why? |
| Sex Factors | 2 | 2020 | 11014 | 0.03 | Why? |
| Infectious Disease Incubation Period | 1 | 2020 | 1033 | 0.03 | Why? |
| Continuous Positive Airway Pressure | 1 | 2021 | 1187 | 0.03 | Why? |
| Suicidal Ideation | 1 | 2020 | 1226 | 0.03 | Why? |
| Leukocyte Count | 1 | 2020 | 3178 | 0.03 | Why? |
| Depressive Disorder | 1 | 2020 | 1236 | 0.02 | Why? |
| Hospitalization | 4 | 2021 | 54280 | 0.02 | Why? |
| Age Factors | 2 | 2020 | 21039 | 0.02 | Why? |
| Adult | 4 | 2020 | 244371 | 0.02 | Why? |
| Ambulatory Care Facilities | 1 | 2020 | 2063 | 0.02 | Why? |
| Sleep Initiation and Maintenance Disorders | 1 | 2020 | 1692 | 0.02 | Why? |
| Lupus Erythematosus, Systemic | 1 | 2019 | 1380 | 0.02 | Why? |
| Hospitals, University | 1 | 2020 | 4173 | 0.02 | Why? |
| Monocytes | 1 | 2020 | 2978 | 0.02 | Why? |
| Lymphocytes | 1 | 2020 | 3056 | 0.02 | Why? |
| Antiviral Agents | 1 | 2020 | 41703 | 0.02 | Why? |
| Oxygen | 1 | 2020 | 3715 | 0.02 | Why? |
| Survival Rate | 1 | 2021 | 9206 | 0.02 | Why? |
| Predictive Value of Tests | 1 | 2021 | 9537 | 0.02 | Why? |
| Hypoxia | 1 | 2020 | 3626 | 0.02 | Why? |
| Arthritis, Rheumatoid | 1 | 2019 | 2043 | 0.02 | Why? |
| Retrospective Studies | 3 | 2021 | 105322 | 0.02 | Why? |
| Ambulatory Care | 1 | 2020 | 4947 | 0.02 | Why? |
| Pandemics | 5 | 2021 | 389249 | 0.02 | Why? |
| Length of Stay | 1 | 2020 | 11042 | 0.01 | Why? |
| Betacoronavirus | 3 | 2020 | 204454 | 0.01 | Why? |
| Risk Factors | 2 | 2021 | 71621 | 0.01 | Why? |
| Case-Control Studies | 1 | 2019 | 17671 | 0.01 | Why? |
| Viral Load | 1 | 2020 | 15850 | 0.01 | Why? |
| Thrombosis | 1 | 2021 | 7504 | 0.01 | Why? |
| Cytokines | 1 | 2020 | 15010 | 0.01 | Why? |
| Prognosis | 1 | 2021 | 32490 | 0.01 | Why? |
| Critical Care | 1 | 2021 | 14081 | 0.01 | Why? |
| Hospital Mortality | 1 | 2021 | 22087 | 0.01 | Why? |
| Risk Assessment | 1 | 2021 | 25439 | 0.01 | Why? |
| Child, Preschool | 1 | 2021 | 36283 | 0.01 | Why? |
| Depression | 1 | 2020 | 14116 | 0.01 | Why? |
| Comorbidity | 1 | 2020 | 34796 | 0.01 | Why? |
| Emergency Service, Hospital | 1 | 2020 | 14232 | 0.01 | Why? |
| Time Factors | 1 | 2018 | 31397 | 0.01 | Why? |
| Anxiety | 1 | 2020 | 17311 | 0.01 | Why? |
| Surveys and Questionnaires | 1 | 2021 | 43792 | 0.01 | Why? |
| Lung | 1 | 2021 | 31049 | 0.01 | Why? |
| Aged, 80 and over | 1 | 2020 | 88759 | 0.01 | Why? |
| Adolescent | 1 | 2020 | 86841 | 0.01 | Why? |
| Young Adult | 1 | 2020 | 93724 | 0.01 | Why? |
De Lorenzo's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(145)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(201)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_